<rss version="2.0">
<channel>
<title>IBTimes.com RSS Feed - PDLI</title>
<description>International Business News - PDLI</description>
<link>http://www.ibtimes.com</link>
<copyright>All articles are copyrighted by IBTimes.com</copyright>

<image>
	<title>The International Business Times - Business News, Updated daily</title> 
	<width>400</width> 
	<height>100</height> 
	<link>http://www.ibtimes.com/</link> 
	<url>http://www.ibtimes.com/images/top_logo_ibt2_3.gif</url> 
</image>


  <item>
  <title>PDL BioPharma names chief executive for spinoff</title>
  <description>PDL BioPharma Inc. said Thursday its board of directors named Faheem Hasnain president and chief executive of its planned spinoff company, Facet Biotech Corp.</description>
    <link>http://www.ibtimes.com/articles/20080925/pdl-biopharma-names-chief-executive-for-spinoff.htm</link> 
  <pubDate>Thu, 25 Sep 2008 09:21:52 EDT</pubDate>
  </item>


  <item>
  <title>Movers roundup: Titan, New York Times</title>
  <description>Among the stock activity stories for Thursday, Sept. 11, from AP Financial News: NEW YORK (AP)--Shares of Titan International Inc. rose Thursday after the maker of off-road vehicle tires ended talks to buy outstanding shares of Titan Europe PLC, an engineering company in which Titan International holds a 17.3 percent stake.</description>
    <link>http://www.ibtimes.com/articles/20080911/movers-roundup-titan-new-york-times.htm</link> 
  <pubDate>Thu, 11 Sep 2008 14:21:19 EDT</pubDate>
  </item>


  <item>
  <title>PDL shares fall following JP Morgan downgrade</title>
  <description>Shares of PDL BioPharma Inc. fell Thursday following negative comments by JP Morgan which called the biotechnology company's royalty stream and development pipeline overvalued by Wall Street.</description>
    <link>http://www.ibtimes.com/articles/20080911/pdl-shares-fall-following-jp-morgan-downgrade.htm</link> 
  <pubDate>Thu, 11 Sep 2008 19:04:50 EDT</pubDate>
  </item>


  <item>
  <title>Movers roundup: Tween Brands, PDL BioPharma</title>
  <description>Among the stock activity stories for Wednesday, Aug. 20, from AP Financial News: NEW YORK (AP)--Shares of Tween Brands Inc. rose on Wednesday, after an analyst said the apparel retailer's plan to convert Limited Too stores into its Justice concept is a positive move.</description>
    <link>http://www.ibtimes.com/articles/20080820/movers-roundup-tween-brands-pdl-biopharma.htm</link> 
  <pubDate>Wed, 20 Aug 2008 15:12:05 EDT</pubDate>
  </item>


  <item>
  <title>PDL BioPharma shares rise on licensing deal</title>
  <description>PDL BioPharma Inc.'s stock gained ground Wednesday after pharma giant Bristol-Myers Squibb Co. signed a deal to license the biotechnology company's developing blood cancer drug.</description>
    <link>http://www.ibtimes.com/articles/20080820/pdl-biopharma-shares-rise-on-licensing-deal.htm</link> 
  <pubDate>Wed, 20 Aug 2008 17:54:33 EDT</pubDate>
  </item>


  <item>
  <title>Bristol-Myers buys rights to PDL BioPharma drug</title>
  <description>Drugmaker Bristol-Myers Squibb Co. said Tuesday it will pay $30 million to acquire rights to an experimental treatment for blood cancer from PDL BioPharma Inc.</description>
    <link>http://www.ibtimes.com/articles/20080819/bristol-myers-buys-rights-to-pdl-biopharma-drug.htm</link> 
  <pubDate>Tue, 19 Aug 2008 18:30:48 EDT</pubDate>
  </item>


  <item>
  <title>PDL BioPharma chief science officer resigns</title>
  <description>PDL BioPharma Inc. said late Monday its chief scientific officer, Richard Murray, will resign to pursue other interests. Murray's resignation is effective Sept. 5.</description>
    <link>http://www.ibtimes.com/articles/20080812/pdl-biopharma-chief-science-officer-resigns.htm</link> 
  <pubDate>Tue, 12 Aug 2008 14:03:49 EDT</pubDate>
  </item>


  <item>
  <title>PDL BioPharma 2nd-qtr profit surges on royalties</title>
  <description>PDL BioPharma Inc. said late Monday its second-quarter profit surged on higher royalty revenue from its antibody products, particularly from biotech giant Genentech Inc.</description>
    <link>http://www.ibtimes.com/articles/20080812/pdl-biopharma-2nd-qtr-profit-surges-on-royalties.htm</link> 
  <pubDate>Tue, 12 Aug 2008 14:02:17 EDT</pubDate>
  </item>


  <item>
  <title>Russell 1000 adds 5 health care stocks</title>
  <description>Five companies in the health care sector were added to the Russell 1000 in this year&amp;#39;s reconstitution of the large stock index, while one stock in the sector was removed.</description>
    <link>http://www.ibtimes.com/articles/20080630/russell-1000-adds-5-health-care-stocks.htm</link> 
  <pubDate>Mon, 30 Jun 2008 12:34:36 EDT</pubDate>
  </item>


  <item>
  <title>PDL BioPharma interim CEO L. Patrick Gage resigns</title>
  <description>PDL BioPharma Inc. said director and interim Chief Executive L. Patrick Gage resigned due to differences among the board about prioritizing company goals.</description>
    <link>http://www.ibtimes.com/articles/20080530/pdl-biopharma-interim-ceo-l-patrick-gage-resigns.htm</link> 
  <pubDate>Fri, 30 May 2008 06:50:05 EDT</pubDate>
  </item>


  <item>
  <title>Partnerships drive big stock gains for small biotechs</title>
  <description>As growth slows in shares of large-cap biotechs and economic woes weigh on the broader markets, investors can find dramatic growth opportunities in many small and midcap biotechs who have secured lucrative research and development partnerships.</description>
    <link>http://www.ibtimes.com/articles/20080521/partnerships-drive-big-stock-gains-for-small-biotechs.htm</link> 
  <pubDate>Wed, 21 May 2008 16:58:51 EDT</pubDate>
  </item>


  <item>
  <title>PDL BioPharma shares hit 5-year low on wider 1Q loss</title>
  <description>Shares of PDL BioPharma Inc. fell Friday, after the company said its first-quarter loss widened on discontinued operations related to the sale of several key drug assets.</description>
    <link>http://www.ibtimes.com/articles/20080509/pdl-biopharma-shares-hit-5-year-low-on-wider-1q-loss.htm</link> 
  <pubDate>Fri, 09 May 2008 17:10:14 EDT</pubDate>
  </item>


  <item>
  <title>PDL Rises After Announcing Spinoff</title>
  <description>
PDL BioPharma shares are surging after the company said it will split up, spinning off its biotechnology assets into a new company and paying a $4.25 dividend to shareholders.

The remaining company ...</description>
    <link>http://www.ibtimes.com/articles/20080411/pdl-rises-after-announcing-spinoff.htm</link> 
  <pubDate>Fri, 11 Apr 2008 14:54:50 EDT</pubDate>
  </item>


  <item>
  <title>Frontier, GE, BlackRock Market Movers</title>
  <description>
Stocks that are moving substantially or trading heavily Friday on the New York Stock Exchange and Nasdaq Stock Market:

NYSE

General Electric Co., down $4.22 at $32.53

After posting a smaller-than-...</description>
    <link>http://www.ibtimes.com/articles/20080411/frontier-ge-blackrock-market-movers.htm</link> 
  <pubDate>Fri, 11 Apr 2008 12:31:17 EDT</pubDate>
  </item>


  <item>
  <title>Opening Glance: Biotech Falls</title>
  <description>
Shares of biotechnology companies are trading lower Friday, after Genentech reported lower-than-expected quarterly revenue due to disappointing sales of cancer drug Avastin. Thomas Weisel Partners an...</description>
    <link>http://www.ibtimes.com/articles/20080411/opening-glance-biotech-falls.htm</link> 
  <pubDate>Fri, 11 Apr 2008 10:10:57 EDT</pubDate>
  </item>


  <item>
  <title>Premarket Movers: GE Falls on 1Q Results</title>
  <description>
General Electric Co. shares slid in premarket trading Friday after the conglomerate reported a smaller-than-expected first-quarter profit and lowered its outlook for the full year, as a slowing U.S. ...</description>
    <link>http://www.ibtimes.com/articles/20080411/premarket-movers-ge-falls-on-1q-results.htm</link> 
  <pubDate>Fri, 11 Apr 2008 09:08:44 EDT</pubDate>
  </item>


  <item>
  <title>Movers Roundup: Mannkind, PDL BioPharma</title>
  <description>Among the stock activity stories for Monday, March 10, from AP Financial News: NEW YORK (AP) _ Shares of MannKind Corp. fell Monday over concerns the biotechnology company may join several peers in ending development of an inhaled insulin product.</description>
    <link>http://www.ibtimes.com/articles/20080310/movers-roundup-mannkind-pdl-biopharma.htm</link> 
  <pubDate>Mon, 10 Mar 2008 13:22:17 EDT</pubDate>
  </item>


  <item>
  <title>PDL BioPharma Shares Continue Sliding</title>
  <description>Shares of PDL BioPharma Inc. stretched their roller-coaster ride Monday, falling again after a week of investor concern over the biotechnology company's move to pull itself off the sales block and cut more jobs.</description>
    <link>http://www.ibtimes.com/articles/20080310/pdl-biopharma-shares-continue-sliding.htm</link> 
  <pubDate>Mon, 10 Mar 2008 10:47:56 EDT</pubDate>
  </item>


  <item>
  <title>PDL Shares Climb After Sharp Drop</title>
  <description>Shares of biotechnology company PDL BioPharma Inc. climbed Thursday, but still could not recover from a sharp drop Wednesday following the announcement it is no longer for sale and will cut additional jobs.</description>
    <link>http://www.ibtimes.com/articles/20080306/pdl-shares-climb-after-sharp-drop.htm</link> 
  <pubDate>Thu, 06 Mar 2008 11:34:16 EST</pubDate>
  </item>


  <item>
  <title>PDL Shares Climbs After Sharp Drop</title>
  <description>Shares of biotechnology company PDL BioPharma Inc. climbed Thursday, but still could not recover from a sharp drop Wednesday following the announcement it is no longer for sale and will cut additional jobs.</description>
    <link>http://www.ibtimes.com/articles/20080306/pdl-shares-climbs-after-sharp-drop.htm</link> 
  <pubDate>Thu, 06 Mar 2008 11:21:21 EST</pubDate>
  </item>


</channel>
</rss>